↓ Skip to main content

Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution

Overview of attention for article published in The Lancet, December 1990
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
2 news outlets
policy
2 policy sources
twitter
22 X users

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution
Published in
The Lancet, December 1990
DOI 10.1016/0140-6736(90)93187-t
Pubmed ID
Authors

M. Pacqué, B. Muñoz, G. Poetscke, J. Foose, H.R. Taylor, B.M. Greene

Abstract

Ivermectin is the drug of choice for community-based treatment of onchocerciasis. Since pregnancy testing during mass distribution campaigns is not feasible, the safety of ivermectin in pregnancy must be established. During a 3-year study, ivermectin was distributed to the population of a rubber plantation (14,000 people) in Liberia. Only 31% of women were aware of their pregnancy status during the first month; it was calculated that about half of women in the first trimester of pregnancy are likely to be treated inadvertently. 203 children born to women inadvertently treated during pregnancy were identified. In this limited sample, there was no significant difference in birth defects between treated and untreated mothers in the same population or compared with a reference population. Children of treated and untreated mothers showed no difference in developmental status or disease patterns. Further surveillance is necessary; however, since no major effects of ivermectin on pregnancy outcome were detected, there seems no need to change existing strategies of ivermectin distribution.

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 20%
Student > Master 9 20%
Other 4 9%
Student > Bachelor 4 9%
Student > Ph. D. Student 3 7%
Other 8 17%
Unknown 9 20%
Readers by discipline Count As %
Medicine and Dentistry 18 39%
Agricultural and Biological Sciences 5 11%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 2 4%
Social Sciences 2 4%
Other 5 11%
Unknown 11 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2024.
All research outputs
#1,121,831
of 25,698,912 outputs
Outputs from The Lancet
#8,403
of 42,916 outputs
Outputs of similar age
#418
of 60,026 outputs
Outputs of similar age from The Lancet
#2
of 96 outputs
Altmetric has tracked 25,698,912 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,916 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 60,026 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.